Your browser doesn't support javascript.
loading
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson's Disease: A Randomized, Placebo-Controlled, Phase 1 Study.
Poewe, Werner; Volc, Dieter; Seppi, Klaus; Medori, Rossella; Lührs, Petra; Kutzelnigg, Alexandra; Djamshidian, Atbin; Thun-Hohenstein, Caroline; Meissner, Wassilios G; Rascol, Olivier; Schneeberger, Achim; Staffler, Günther; Poewe, Werner; Seppi, Klaus; Djamshidian, Atbin; deMarzi, Roberto; Heim, Beatrice; Mangesius, Stephanie; Stolz, Raphaela; Wachowicz, Katarzyna; Volc, Dieter; Thun-Hohenstein, Caroline; Riha, Constanze; Schneeberger, Achim; Bürger, Vera; Galabova, Gergana.
Afiliação
  • Poewe W; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Volc D; PROSENEX Study Center at Privatklinik Confraternitaet, Vienna, Austria.
  • Seppi K; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Medori R; AFFiRiS AG, Vienna, Austria.
  • Lührs P; AFFiRiS AG, Vienna, Austria.
  • Kutzelnigg A; AFFiRiS AG, Vienna, Austria.
  • Djamshidian A; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Thun-Hohenstein C; PROSENEX Study Center at Privatklinik Confraternitaet, Vienna, Austria.
  • Meissner WG; Service de Neurologie, CRMR Atrophie Multisystématisée, CHU Bordeaux and Université Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, France.
  • Rascol O; Toulouse Parkinson Expert Center, Departments of Neurosciences and Clinical Pharmacology, Centre d'Investigation Clinique de Toulouse CIC1436, NS-Park/FCRIN Network, and NeuroToul COEN Center, University Hospital of Toulouse, INSERM, University of Toulouse, Toulouse, France.
  • Schneeberger A; AFFiRiS AG, Vienna, Austria.
  • Staffler G; Accanis GmbH, Vienna, Austria.
  • Seppi K; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Djamshidian A; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • deMarzi R; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Heim B; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Mangesius S; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Stolz R; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Wachowicz K; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Volc D; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Thun-Hohenstein C; PROSENEX Study Center at Privatklinik Confraternitaet, Vienna, Austria.
  • Riha C; PROSENEX Study Center at Privatklinik Confraternitaet, Vienna, Austria.
  • Schneeberger A; PROSENEX Study Center at Privatklinik Confraternitaet, Vienna, Austria.
  • Bürger V; AFFiRiS AG, Vienna, Austria.
  • Galabova G; AFFiRiS AG, Vienna, Austria.
J Parkinsons Dis ; 11(3): 1079-1089, 2021.
Article em En | MEDLINE | ID: mdl-34092654
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína Idioma: En Ano de publicação: 2021 Tipo de documento: Article